Ray Dalio's RGEN Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 33,616 shares of Repligen Corporation (RGEN) worth $4.49 M, representing 0.02% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in RGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 26,718 shares. Largest reduction occurred in Q3 2022, reducing 1,386 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2021 | +736 | New Buy | 736 | $289.40 |
| Q4 2021 | -736 | Sold Out | 736 | $0.00 |
| Q1 2022 | +2,992 | New Buy | 2,992 | $188.17 |
| Q2 2022 | +618 | Add 20.66% | 3,610 | $162.33 |
| Q3 2022 | -1,386 | Reduce 38.39% | 2,224 | $187.05 |
| Q4 2022 | +4,674 | Add 210.16% | 6,898 | $169.31 |
| Q1 2023 | -6,898 | Sold Out | 6,898 | $0.00 |
| Q3 2025 | +33,616 | New Buy | 33,616 | $133.67 |
Ray Dalio's Repligen Corporation Investment FAQs
Ray Dalio first purchased Repligen Corporation (RGEN) in Q3 2021, acquiring 736 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Repligen Corporation (RGEN) for 17 quarters since Q3 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Repligen Corporation (RGEN) was in Q3 2025, adding 33,616 shares worth $4.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 33,616 shares of Repligen Corporation (RGEN), valued at approximately $4.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Repligen Corporation (RGEN) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Repligen Corporation (RGEN) was 33,616 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.